The SPAC4G8.03c Antibody targets the Sup11 protein, a critical component in fungal cell wall integrity and cytokinesis. Sup11p shares homology with Saccharomyces cerevisiae Kre9, which is implicated in β-1,6-glucan synthesis. This antibody enables researchers to track Sup11p localization, expression levels, and functional interactions under varying genetic or environmental conditions .
Function: Essential for β-1,6-glucan synthesis, septum assembly, and cell viability .
Domains: Contains a S/T-rich region prone to O-mannosylation, masking an unusual N-X-A sequon for N-glycosylation in mutants .
Specificity: Binds to hypo-mannosylated Sup11p in O-mannosylation-deficient strains.
Applications: Used in Western blotting, immunofluorescence, and protein localization studies .
Depletion of Sup11p leads to:
Upregulation of glucanases (e.g., Gas2p) and glucan-modifying enzymes, indicating compensatory cell wall remodeling .
Morphological Defects: Sup11p-depleted cells exhibit malformed septa with excessive β-1,3-glucan deposits .
Genetic Interactions: Synergizes with Gas2p (a β-1,3-glucanosyl-transferase) to regulate septum composition .
| Phenotype | Observation |
|---|---|
| Cell viability | Lethal in haploid strains |
| Septum structure | Accumulation of β-1,3-glucan at malformed septa |
| Glycosylation status | Hypo-mannosylated Sup11p detected in oma4Δ mutants |
| β-1,6-glucan levels | Undetectable in cell wall extracts |
Cell Biology: Mapping Sup11p’s role in β-1,6-glucan synthesis and septum maturation .
Glycosylation Studies: Investigating competition between O- and N-glycosylation in S/T-rich domains .
Therapeutic Insights: Understanding fungal cell wall vulnerabilities for antifungal drug development .
Western Blot: Confirmed Sup11p expression in wild-type and glycosylation mutants .
Mass Spectrometry: Identified Sup11p interactions with glucan synthases and remodeling enzymes .
Microarray Analysis: Revealed global transcriptional changes in cell wall-related genes .
While camelid single-domain antibodies (e.g., VHHs) and human monoclonal antibodies (e.g., REGEN-COV) target pathogens via unique mechanisms , the SPAC4G8.03c Antibody focuses on fungal structural biology. Its utility parallels antibodies like Abs-9 (Staphylococcus aureus) or CD4-Nbs , which also address microbial evasion mechanisms.
Structural Studies: Cryo-EM analysis of Sup11p complexes.
Therapeutic Screening: Targeting β-1,6-glucan synthesis pathways in pathogenic fungi.
SPAC4G8.03c is a gene encoding a transport protein in the fission yeast Schizosaccharomyces pombe. Based on current research, this gene appears to be related to the Str2 protein, which plays a crucial role in iron homeostasis and siderophore transport. Researchers study this protein to understand fundamental cellular processes involving nutrient acquisition and metal homeostasis in eukaryotic cells. The study of such transport proteins provides insights into conserved cellular mechanisms that may have broader implications for understanding human cellular biology .
When validating antibodies against fission yeast proteins like SPAC4G8.03c, researchers should employ multiple complementary approaches:
Genetic validation: Use knockout strains (e.g., str2Δ) as negative controls to confirm absence of signal
Western blotting: Compare bands between wild-type and deletion strains
Immunoprecipitation followed by mass spectrometry: Verify the identity of pulled-down proteins
Fluorescent tagging confirmation: Compare antibody localization patterns with GFP-tagged versions of the target protein
These approaches align with standardized consensus antibody characterization protocols that are openly available to the scientific community, ensuring robust validation .
When interpreting Western blot results for SPAC4G8.03c, consider:
Expected molecular weight: Confirm the band appears at the predicted size
Specificity controls: Always include a negative control (str2Δ or equivalent knockout strain)
Expression conditions: Iron levels significantly affect expression of transport proteins in S. pombe; iron chelation with 2,2′-dipyridyl (Dip, 250 μM) often increases expression of iron transport proteins, while FeCl₃ (100 μM) supplementation typically decreases expression
Secondary antibody selection: Ensure appropriate selection based on the host species of your primary antibody
Proper sample preparation, including effective cell lysis techniques appropriate for yeast cells, is essential for reliable results. Consider using whole cell extracts analyzed with appropriate molecular weight markers as reference points .
Optimizing immunoprecipitation for membrane-associated proteins like SPAC4G8.03c requires special considerations:
Membrane solubilization: Use appropriate detergents (e.g., 1% NP-40 or 0.5% Triton X-100) to effectively extract membrane proteins
Compartment-specific isolation: For vacuolar proteins like Str2, consider using vacuole purification protocols prior to immunoprecipitation
Cross-linking considerations: Light cross-linking (0.1-0.5% formaldehyde) may help preserve transient protein interactions
Buffer optimization: Adjust salt concentrations (150-300 mM NaCl) to maintain specific interactions while reducing background
For proteins that show condition-dependent localization, perform immunoprecipitation under both basal and stimulated conditions (e.g., iron-replete vs. iron-deficient) .
Critical factors include:
Media composition: Standardize media preparation, particularly regarding trace metal content
Growth phase consistency: Harvest cells at consistent optical density (e.g., OD₆₀₀ of 1.0)
Treatment timing: Standardize duration of iron manipulation (typically 1.5-3 hours for acute responses)
Chelator concentration: Use consistent concentrations of iron chelators (e.g., 250 μM Dip for iron deficiency)
Temperature control: Maintain consistent growth temperature throughout experiments
| Condition | Treatment | Duration | Expected Effect on SPAC4G8.03c Expression |
|---|---|---|---|
| Iron deficiency | 250 μM Dip | 3 hours | Increased expression |
| Iron repletion | 100 μM FeCl₃ | 3 hours | Decreased expression |
| Siderophore supplementation | 1 μM holo-Fc | 1 hour (following Dip) | Potential modulation of expression |
Monitoring expression through both protein (Western blot) and transcript levels provides more comprehensive insights into regulatory mechanisms .
Advanced imaging approaches for studying SPAC4G8.03c include:
Live-cell time-lapse microscopy: Track protein movement in response to changing iron levels
Fluorescence Recovery After Photobleaching (FRAP): Analyze protein mobility within membranes
Co-localization studies: Combine with organelle markers (e.g., vacuolar markers) to confirm precise subcellular localization
Super-resolution microscopy: Resolve detailed subcellular structures beyond the diffraction limit
For optimal results, consider using a C-terminal GFP tag, which has been successfully employed for similar transport proteins in fission yeast. Confirm that the tagged protein remains functional through complementation assays. Fluorescence microscopy can effectively visualize localization patterns, which can be correlated with cell morphology using Nomarski optics .
To address non-specific binding:
Blocking optimization: Test different blocking agents (5% BSA, 5% non-fat milk, commercial blocking buffers)
Antibody titration: Determine optimal antibody concentration through dilution series
Wash buffer modification: Adjust stringency by altering salt concentration and detergent levels
Pre-adsorption: Incubate antibody with lysate from knockout strains to remove non-specific antibodies
Epitope competition: Use synthetic peptides corresponding to the antibody epitope for validation
Follow standardized consensus antibody characterization protocols that emphasize proper controls and validation steps .
When facing discrepancies:
Systematic validation: Compare results across multiple techniques (Western blot, immunofluorescence, mass spectrometry)
Expression system analysis: Consider differences between endogenous expression and overexpression systems
Epitope accessibility: Evaluate whether protein conformation or complex formation might mask epitopes in certain assays
Cross-reactivity assessment: Verify antibody specificity against closely related proteins
Method-specific controls: Include appropriate positive and negative controls for each technique
Document all experimental conditions thoroughly to enable accurate interpretation of discrepancies. Consider that different detection methods may reveal different aspects of protein biology, and discrepancies might reflect biological reality rather than technical issues .
Best practices include:
Multiple complementary approaches:
Co-immunoprecipitation followed by immunoblotting
Proximity labeling techniques (BioID, APEX)
Yeast two-hybrid screening
Fluorescence resonance energy transfer (FRET)
Condition-specific analysis: Assess interactions under different iron availability conditions, as protein-protein interactions in iron transport pathways are often condition-dependent. Studies of similar systems show that proteins like Sib2 and Sib3 interact specifically under iron-deficient conditions .
Crosslinking considerations: For transient interactions, consider chemical crosslinking prior to analysis
Control experiments:
Bait-only controls
Unrelated protein controls
Reciprocal co-immunoprecipitations
Recent protein-protein interaction studies in fission yeast have successfully revealed condition-dependent interactions between proteins involved in iron metabolism pathways, providing useful methodological frameworks for similar studies with SPAC4G8.03c .
Genetic background considerations include:
Knockout validation: Generate a clean deletion strain (spac4g8.03cΔ) as a negative control using the kanamycin/G418 resistance gene (kanMX) cassette flanked by loxP sequences
Transcriptional regulator effects: Consider testing in both wild-type and regulatory mutant backgrounds (e.g., fep1Δ for iron-regulated genes)
Strain history documentation: Maintain detailed records of strain construction and validation
Background mutation assessment: Sequence verify key strains to confirm the absence of suppressor mutations
When analyzing results, compare expression and localization patterns between different genetic backgrounds under standardized conditions. The use of the Cre recombinase/loxP-mediated removal process can facilitate the construction of multiple deletion strains .
A comprehensive experimental design should include:
Time course analysis: Monitor expression at multiple time points (e.g., 0, 1.5, 3, 6 hours) after iron manipulation
Concentration gradients: Test varying concentrations of iron chelators and iron supplementation
Multiple iron sources: Compare responses to different iron sources (e.g., FeCl₃, heme, ferrichrome)
Combined transcriptomic and proteomic analysis: Assess both mRNA and protein levels simultaneously
Parallel analysis of known iron-responsive genes: Include established controls (e.g., other iron transporters)
Start cultures at a standardized optical density (OD₆₀₀ of 0.5) and perform treatments when cultures reach OD₆₀₀ of 1.0. This approach enables detection of both immediate and adaptive responses to changing iron availability .
For post-translational modification analysis:
Mass spectrometry approaches:
Enrichment strategies for specific modifications (phosphorylation, ubiquitination)
Targeted MS/MS analysis of predicted modification sites
Comparison of modification patterns under different conditions
Mobility shift assays:
Use Phos-tag gels for phosphorylation detection
Employ deglycosylation enzymes to assess glycosylation
Site-directed mutagenesis:
Generate mutants of predicted modification sites
Assess functional consequences through complementation assays
Modification-specific antibodies:
When available, use antibodies that recognize specific modifications
Validate specificity using appropriate controls
Analysis of post-translational modifications provides crucial insights into regulatory mechanisms controlling protein function, localization, and stability in response to environmental changes.
High-throughput adaptation strategies include:
Antibody microarrays: Test multiple antibodies simultaneously against protein extracts from various conditions
Automated Western blotting platforms: Standardize testing across multiple samples and conditions
Multiplexed immunofluorescence: Analyze multiple proteins simultaneously in single samples
Machine learning analysis: Implement automated image analysis for quantitative assessment of staining patterns
These approaches enable systematic evaluation of antibody performance across diverse experimental variables, similar to the standardized platforms used for antibody characterization in other systems .
Promising emerging technologies include:
Single B-cell sequencing: Enables rapid identification and cloning of antibody sequences, as demonstrated in recent studies where high-throughput single-cell RNA and VDJ sequencing identified 676 antigen-binding IgG1+ clonotypes
Phage display libraries: Allow screening of large antibody repertoires against specific epitopes
AI-guided epitope prediction: Computational approaches using AlphaFold2 and molecular docking methods can predict antigenic epitopes for antibody binding
Nanobody development: Single-domain antibodies offer advantages for certain applications due to their small size and stability
These technologies provide opportunities to develop highly specific antibodies with defined binding characteristics, potentially improving specificity and reducing cross-reactivity issues .
Integration strategies include:
Multi-omics data correlation:
Map antibody-detected protein levels to transcriptomic data
Correlate localization patterns with interactome data
Integrate with metabolomic profiles, particularly iron-related metabolites
Network analysis:
Place SPAC4G8.03c in the context of iron homeostasis networks
Identify functional modules through clustering algorithms
Predict novel interactions based on network topology
Temporal dynamics modeling:
Develop mathematical models of protein expression and localization dynamics
Simulate system responses to perturbations
Validate model predictions experimentally
Cross-species comparison:
Compare with orthologous proteins in other model organisms
Identify conserved regulatory mechanisms
This integrated approach provides a comprehensive understanding of protein function within the broader cellular context, extending beyond isolated observations to systems-level insights.